ÂÜŔňÂŇÂ×

Joseph Truluck was appointed as the Chief Operating Officer and CFO in 2017 and, since May 2016, has been the VP of Operations and Finance. Since January 2013, Mr. Truluck has served as the VP of Operations and Finance at Adenosine Therapeutics, after the company reacquired its major drug development program. As VP, Operations & Finance, at Adenosine Therapeutics, Mr. Truluck has overseen the operations of the business, including seeing to completion a project to merge and analyze two partially completed Phase 3 trials to constitute a single trial. Previously, Mr. Truluck served as the Operations Manager of Adenosine Therapeutics’ until its purchase by Clinical Data (NASDAQ: CLDA). He is the co-founder and former VP of Operations and Finance for Beonten, Inc., a software development company. Beonten’s goal was the creation of a software platform for knowledge management and sharing. Beonten was a Semi-Finalist in the prestigious MIT 100K business plan competition. Mr. Truluck has an MBA from Tulane University with a concentration in Finance and an MA in Philosophy at the University of Virginia, with a thesis in the area of modal semantics.